Interferon-α resistance in a cutaneous T-cell lymphoma cell line is associated with lack of STAT1 expression

Blood

Volumn 91, Issue 2, 1998, Pages 570-576

  Sun, Wenn H ^a   Pabon, Carlos ^b   Alsayed, Yazan ^b   Huang, Paul P ^b   Jandeska, Sara ^b   Uddin, Shahab ^b   Platanias, Leonidas C ^b   Rosen, Steven T ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; RECOMBINANT ALPHA2A INTERFERON; STAT1 PROTEIN;

ARTICLE; CANCER IMMUNOTHERAPY; CANCER RESISTANCE; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SKIN LYMPHOMA; T CELL LYMPHOMA;

EID: 0031962552     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.2.570.570_570_576     Document Type: Article

References (38)

1. Petska S, Langer JA, Zoon KC, Samuel CE: Interferons and their actions. Annu Rev Biochem 56:727, 1987
2. Platanias LC: Interferons: Laboratory to clinic investigations. Curr Opin Oncol 7:560, 1995
3. Uze G, Lutfalla G, Mongensen KE: α And β interferons and their receptor and their friends and relations. J Interferon Res 15:3, 1995
4. Darnell J, Kerr IM, Stark GR: Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415, 1994
5. Ihle JN, Witthuhn BA, Quelle FW, Yamamoto K, Thierfelder WE, Kreider B, Silvenoinen O: Signaling by the cytokine receptor superfamily: JAKs and STATs. Trends Biochem Sci 19:222, 1994
6. Platanias LC, Uddin S, Colamonici OR: Tyrosine phosphorylation of the alpha and beta subunits of the type I interferon receptor. Interferon-beta selectively induces tyrosine phosphorylation of an alpha subunit-associated protein. J Biol Chem 269:17761, 1994
7. Platanias LC, Colamonici OR: Interferon alpha induces rapid tyrosine phosphorylation of the alpha subunit of its receptor. J Biol Chem 267:24053, 1992
8. Meraz MA, White JM, Sheehan KCF, Bach EA, Rodig SJ, Dighe AS, Kaplan DH, Riley JK, Greenlund AC, Campbell D, Carver-Moore K, DuBois RN, Clark R, Aguet M, Schreiber RD: Targeted disruption of the Stat1 gene in mice reveals unexpected physiological specificity in the JAK-STAT signaling pathway. Cell 84:431, 1996
9. Fu X-Y, Schindler C, Improta T, Aebersold R, Darnell JD: The proteins of ISGF-3, the interferon alpha-induced transcriptional activator, define a gene family involved in signal transduction. Biochemistry 89:7840, 1992
10. Schindler C, Fu X-Y, Improta T, Aebersold R, Darnell JD: Proteins of transcription factor ISGF-3: One gene encodes the 91-and 84-kDa ISGF-3 proteins that are activated by interferon alpha. Proc Natl Acad Sci USA 89:7836, 1992
11. Qureshi SA, Leung S, Kerr IM, Stark GR, Darnell JE: Function of Stat2 protein in transcriptional activation by alpha interferon. Mol Cell Biol 16:288, 1996
12. The genomic structure of the murine ICSBP gene reveals the presence of the gamma interferon-responsive element, to which an ISGF3 alpha subunit or similar molecule binds. Mol Cell Biol 13:3951, 1993
13. Gutterman JU: Cytokine therapeutics: Lessons from interferon α. Proc Natl Acad Sci USA 91:1198, 1994
14. Ross C, Tingsgaard P, Jorgensen H, Veilsgaard GL: Interferon treatment of cutaneous T cell lymphoma. Eur J Haematol 51:63, 1993
15. Kuzel TM, Roenigk HH, Samuelson E, Herrmann JJ, Hurria A, Rademaker AW, Rosen ST: Effectiveness of interferon alpha-2a combined with phototherapy for mycosis fungoides and the Sezary syndrome. J Clinic Oncol 13:257, 1995
16. Steis RG, Smith II JW, Urba WJ, Venzon DJ, Longo DL, Barney R, Evans LM, Itri LM, Ewel CH: Loss of interferon antibodies during prolonged continuous interferon-α2a therapy in hairy cell leukemia. Blood 77:792, 1991
17. Del Mel WCP, Hoffbrand AV, Giles FJ, Goldstone AH, Mehta AB, Ganeshaguru K: Alpha interferon therapy for haematological malignancies: Correlation between in vivo induction of 2′5′ oligoadenylate synthetase and clinical response. Brit J Haematol 74:452, 1990
18. Rutherford MN, Hannigan GE, Williams BRG: Interferon-induced binding of nuclear factors to promoter elements of the 2-5A synthetase gene. EMBO J 7:751, 1988
19. Uze G, Lutfalla G, Gresser I: Genetic transfer of a functional human interferon alpha receptor into mouse cells: Cloning and expression of its cDNA. Cell 60:225, 1990
20. Gazdar AF, Carney DN, Bunn PA, Russel EK, Jaffe ES, Schechter GP, Guccion JG: Mitogen requirements for the in vitro propagation of cutaneous T cell lymphoma. Blood 55:409, 1980
21. Friedman RL, Stark GR: Alpha-interferon-induced transcription of HLA and metallothionein genes containing homologous upstream sequences. Nature 314:637, 1985
22. Verhaegen M, Divizia M, Vandenbussche P, Kuwata T, Content J: Abnormal behavior of interferon-induced enzymatic activities in an interferon-resistant cell line. Proc Natl Acad Sci USA 77:4479, 1980
23. Tovey MG, Dron M, Mogensen KE, Lebleu B, Mechti N, Begonlours-Guymarho J: Isolation of Daudi cells with reduced sensitivity to interferon II. On the mechanism of resistance. J Gen Virol 64:2649, 1983
24. Morikawa K, Morikawa R, Killion JJ, Fan D, Fidler IJ: Isolation of human colon carcinoma cells for resistance to a single interferon associated with cross-resistance to multiple recombinant interferons: Alpha, beta, and gamma. J Natl Cancer Inst 82:517, 1990
25. Gomi K, Akinaga S, Oka T, Morimoto M: Analysis of receptors, cell surface antigens, and proteins in human melanoma cell lines resistant to human recombinant beta-or gamma-interferon. Cancer Res 46:6211, 1986
26. Colamonici OR, Porterfield B, Domanski P, Constantinescu S, Pfeffer LM: Complementation of the interferonα response in resistant cells by expression of the cloned subunit of the interferonα receptor. J Biol Chem 13:9598, 1994
27. Abramovich C, Shulman LM, Ratovitski E, Harroch S, Tovey M, Eid P, Revel M: Differential tyrosine phosphorylation of the IFNR chain of the type I interferon receptor and of an associated surface protein in response to IFNα and IFNβ. EMBO J 13:5871, 1994
28. McKendry R, John J, Flavell D, Muller M, Kerr IM, Stark GR: High frequency mutagenesis of human cells and characterization of a mutant unresponsive to both α and γ interferons. Proc Natl Acad Sci USA 88:11455, 1991
29. Bromberg JF, Horvath CM, Wen Z, Schreiber RD, Darnell JE, Jr: Transcriptionally active STAT1 is required for the antiproliferative effects of both interferonα and interferonγ. Proc Natl Acad Sci USA 93:7673, 1996
30. waf1/cipi mediated by STAT1. Science 272:719, 1996
31. Leung S, Qureshi SA, Kerr IM, Darnell JE, Stark GR: Role of STAT2 in the alpha interferon signaling pathway. Mol Cell Biol 15:1312, 1995
32. Qureshi SA, Leung S, Kerr IM, Stark GR, Darnell JE, Jr: Function of STAT2 protein in transcriptional activation by alpha interferon. Mol Cell Biol 16:288, 1996
33. Improta T, Schindler C, Horvath CM, Kerr IM, Stark GR, Darnell JE: Transcription factor ISGF3 formation requires phosphorylated STAT91 protein, but STAT113 protein is phosphorylated independently of STAT91 protein. Proc Natl Acad Sci USA 91:4776, 1994
34. Durbin JE, Hackenmiller R, Celeste Simon M, Levy DE: Targeted disruption of the mouse STAT1 gene results in compromised innate immunity to viral disease. Cell 84:443, 1996
35. Velazquez L, Mogensen KE, Barbieri G, Fellous M, Uze G, Pellegrini S: Distinct domains of the protein tyrosine kinase tyk2 required for binding of interferon-α/β and for signal transduction. J Biol Chem 270:3327, 1995
36. Zhang Q, Nowak I, Vondeerheid EC, Rook AH, Kadin ME, Nowell PC, Shaw LM, Wasik MA: Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin-2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome. Proc Natl Acad Sci USA 93:9148, 1996
37. Gouilleux-Gruart V, Gouilleux F, Desaint C, Claisse J-F, Capiod J-C, Delobel J, Weber-Nordt R, Dusanter-Fourt I, Dreyfus F, Groner B, Prin L: STAT-related transcription factors are constitutively activated in peripheral blood cells from acute leukemia patients. Blood 87:1692, 1996
38. Yu C-L, Meyer DJ, Campbell GS, Lamer AC, Carter-Su C, Schwartz J, Jove R: Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. Science 269:81, 1995